Literature DB >> 20627689

Side effects of spiramycin masquerading as local anesthetic toxicity during labor epidural analgesia.

B Julliac1, H Théophile, M Begorre, B Richez, F Haramburu.   

Abstract

Significant fetal bradycardia occurred when a parturient receiving labor epidural analgesia experienced generalized numbness and tingling, a metallic taste and hot flushes. An emergent cesarean delivery under general anesthesia was performed with favorable outcomes for the mother and baby. The most likely source of the maternal symptoms was spiramycin, which was being administered for treatment of toxoplasmosis. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20627689     DOI： 10.1016/j.ijoa.2010.03.002

Source DB:  PubMed          Journal:  Int J Obstet Anesth        ISSN： 0959-289X            Impact factor:   2.603


  8 in total

1.  Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis.

Authors:  Matthew A Hulverson; Igor Bruzual; Erin V McConnell; Wenlin Huang; Rama S R Vidadala; Ryan Choi; Samuel L M Arnold; Grant R Whitman; Molly C McCloskey; Lynn K Barrett; Kasey L Rivas; Suzanne Scheele; Amy E DeRocher; Marilyn Parsons; Kayode K Ojo; Dustin J Maly; Erkang Fan; Wesley C Van Voorhis; J Stone Doggett
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

2.  Novel Synergistic Protective Efficacy of Atovaquone and Diclazuril on Fetal-Maternal Toxoplasmosis.

Authors:  Helieh S Oz
Journal:  Int J Clin Med       Date:  2014-08

3.  Atovaquone ameliorate gastrointestinal toxoplasmosis complications in a pregnancy model.

Authors:  Helieh S Oz; Thomas Tobin
Journal:  Med Sci Monit       Date:  2012-09

4.  Diclazuril Protects against Maternal Gastrointestinal Syndrome and Congenital Toxoplasmosis.

Authors:  Helieh S Oz; Thomas Tobin
Journal:  Int J Clin Med       Date:  2014-01-01

Review 5.  A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).

Authors:  Mahbobeh Montazeri; Mehdi Sharif; Shahabeddin Sarvi; Saeed Mehrzadi; Ehsan Ahmadpour; Ahmad Daryani
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

6.  Ginsenoside Rh2 reduces depression in offspring of mice with maternal toxoplasma infection during pregnancy by inhibiting microglial activation via the HMGB1/TLR4/NF-κB signaling pathway.

Authors:  Xiang Xu; Yu-Nan Lu; Jia-Hui Cheng; Hui-Wen Lan; Jing-Mei Lu; Guang-Nan Jin; Guang-Hua Xu; Cheng-Hua Jin; Juan Ma; Hu-Nan Piao; Xuejun Jin; Lian-Xun Piao
Journal:  J Ginseng Res       Date:  2021-04-28       Impact factor: 6.060

7.  In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against Toxoplasma gondii.

Authors:  Yazhen Ma; Xinru Cao; Hui Wang; Xingju Song; Dandan Hu
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

8.  Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone.

Authors:  Helieh S Oz
Journal:  Front Microbiol       Date:  2014-09-15       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.